GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seres Therapeutics Inc (FRA:1S9) » Definitions » E10

Seres Therapeutics (FRA:1S9) E10 : €-1.89 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Seres Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Seres Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was €0.523. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.89 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-01-18), Seres Therapeutics's current stock price is €0.7242. Seres Therapeutics's E10 for the quarter that ended in Sep. 2024 was €-1.89. Seres Therapeutics's Shiller PE Ratio of today is .


Seres Therapeutics E10 Historical Data

The historical data trend for Seres Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seres Therapeutics E10 Chart

Seres Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1.75

Seres Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.91 -1.75 -1.84 -2.05 -1.89

Competitive Comparison of Seres Therapeutics's E10

For the Biotechnology subindustry, Seres Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seres Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seres Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Seres Therapeutics's Shiller PE Ratio falls into.



Seres Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Seres Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.523/133.0289*133.0289
=0.523

Current CPI (Sep. 2024) = 133.0289.

Seres Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201412 -0.230 99.070 -0.309
201503 -0.201 99.621 -0.268
201506 -1.292 100.684 -1.707
201509 -0.339 100.392 -0.449
201512 -0.461 99.792 -0.615
201603 -0.449 100.470 -0.595
201606 -0.623 101.688 -0.815
201609 -0.410 101.861 -0.535
201612 -0.597 101.863 -0.780
201703 -0.589 102.862 -0.762
201706 -0.614 103.349 -0.790
201709 -0.143 104.136 -0.183
201712 -0.608 104.011 -0.778
201803 -0.560 105.290 -0.708
201806 -0.582 106.317 -0.728
201809 -0.463 106.507 -0.578
201812 -0.457 105.998 -0.574
201903 -0.522 107.251 -0.647
201906 -0.212 108.070 -0.261
201909 -0.209 108.329 -0.257
201912 -0.225 108.420 -0.276
202003 -0.253 108.902 -0.309
202006 -0.249 108.767 -0.305
202009 -0.306 109.815 -0.371
202012 -0.156 109.897 -0.189
202103 -0.328 111.754 -0.390
202106 -0.440 114.631 -0.511
202109 0.612 115.734 0.703
202112 -0.487 117.630 -0.551
202203 -0.554 121.301 -0.608
202206 -0.662 125.017 -0.704
202209 -0.495 125.227 -0.526
202212 -0.510 125.222 -0.542
202303 -0.532 127.348 -0.556
202306 0.332 128.729 0.343
202309 -0.347 129.860 -0.355
202312 -0.293 129.419 -0.301
202403 -0.248 131.776 -0.250
202406 -0.204 132.554 -0.205
202409 0.523 133.029 0.523

Add all the adjusted EPS together and divide 10 will get our e10.


Seres Therapeutics  (FRA:1S9) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Seres Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Seres Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Seres Therapeutics Business Description

Traded in Other Exchanges
Address
101 Cambridgepark Drive, Cambridge, MA, USA, 02140
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Seres Therapeutics Headlines

No Headlines